# ELEVANCE HEALTH, INC. (ELV) FY2025 Q1 Balance Sheet

- Company: ELEVANCE HEALTH, INC. (ELV)
- Period: As of 2025-03-31
- Filing: Q1 FY2025 10-Q, filed 2025-04-22, accession number 0001156039-25-000057
- Page: https://plicit.ai/financials/elv/fy2025-q1-balance-sheet
- Chart image: https://plicit.ai/charts/elv-fy2025-q1-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2025-03-31. The chart shows assets, liabilities and equity at that date.

- **Assets**: 119,717,000,000 US dollars
- **Current assets**: 61,121,000,000 US dollars
- **Non-current assets**: 58,596,000,000 US dollars
- **Liabilities**: 77,097,000,000 US dollars
- **Current liabilities**: 42,698,000,000 US dollars
- **Non-current liabilities**: 34,399,000,000 US dollars
- **Equity**: 42,620,000,000 US dollars
- **Noncontrolling interest**: 117,000,000 US dollars. Included in consolidated equity; this amount is not added again.
- **Fixed maturity securities (amortized cost of $25,813 and $25,879; allowance for credit losses of $7 and $6)**: 25,437,000,000 US dollars
- **Premium receivables**: 10,359,000,000 US dollars
- **Cash and cash equivalents**: 7,500,000,000 US dollars
- **Other receivables**: 6,576,000,000 US dollars
- **Other current assets**: 5,288,000,000 US dollars
- **Self-funded receivables**: 5,246,000,000 US dollars
- **Equity securities**: 715,000,000 US dollars
- **Assets held for sale**: 0 US dollars
- **Goodwill**: 28,420,000,000 US dollars
- **Other intangible assets**: 11,940,000,000 US dollars
- **Other invested assets**: 10,167,000,000 US dollars
- **Property and equipment, net**: 4,617,000,000 US dollars
- **Other noncurrent assets**: 2,392,000,000 US dollars
- **Fixed maturity securities (amortized cost of $1,070 and $1,049; allowance for credit losses of $0 and $0)**: 1,060,000,000 US dollars
- **Medical claims payable**: 16,812,000,000 US dollars
- **Other current liabilities**: 11,426,000,000 US dollars
- **Accounts payable and accrued expenses**: 7,131,000,000 US dollars
- **Other policyholder liabilities**: 3,796,000,000 US dollars
- **Current portion of long-term debt**: 1,643,000,000 US dollars
- **Unearned income**: 1,640,000,000 US dollars
- **Short-term borrowings**: 250,000,000 US dollars
- **Liabilities held for sale**: 0 US dollars
- **Long-term debt, less current portion**: 28,110,000,000 US dollars
- **Other noncurrent liabilities**: 3,994,000,000 US dollars
- **Deferred tax liabilities, net**: 2,121,000,000 US dollars
- **Reserves for future policy benefits**: 174,000,000 US dollars
- **Retained earnings**: 34,546,000,000 US dollars
- **Additional paid-in capital**: 8,866,000,000 US dollars
- **Common stock, par value $0.01, shares authorized – 900,000,000; shares issued and outstanding – 225,641,361 and 227,479,695**: 2,000,000 US dollars
- **Preferred stock, without par value, shares authorized – 100,000,000; shares issued and outstanding – none**: 0 US dollars
- **Noncontrolling interests**: 117,000,000 US dollars
- **Accumulated other comprehensive loss**: negative 911,000,000 US dollars
- **Gross equity (calculated)**: 43,531,000,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.
